Breaking down barriers: new partnership offers English language support to international scientific authors
12 Mar 2011
BioMed Central’s agreement with Edanz provides researchers with cost-effective and comprehensive English language support throughout publication process
Open access publisher BioMed Central has announced an agreement with Edanz, a leading medical and scientific editing service provider, to offer full English language support to researchers publishing in BioMed Central journals. As part of this agreement, BioMed Central authors will be eligible to receive a discount on Edanz’s services.
Edanz has been operating in East Asia for more than 15 years as well as supporting non-English speaking authors throughout the world. East Asia is the fastest growing source of papers for all STM publishers: the number of peer-reviewed papers published by Chinese researchers alone has risen 64-fold over the past 30 years. BioMed Central has also seen significant growth in the number of published articles from authors based in mainland China and across the region. BioMed Central’s agreement with Edanz will significantly improve the publishing experience of authors worldwide, allowing them to obtain English language assistance wherever an author needs it through the entire publication process. Edanz’s services are provided by expert scientists and will support authors through manuscript submission, peer-review, addressing reviewers’ comments, as well as assistance with writing cover letters and advising on the most appropriate journal for their papers. In addition, Edanz will be providing free workshops and training materials for BioMed Central authors concentrating on how to write a scientific manuscript. This training program will initially begin in China and Japan but will later expand to other important regions.
Deborah Kahn, BioMed Central Publishing Director, said, “our relationship with Edanz will offer authors submitting to our journals a complete, rounded English language service. The number of papers submitted to us from China alone has grown 168% in the past two years, so working with Edanz will provide greater value to authors from this region as well as ensuring their papers meet the linguistic demands for publication.”
Kerry Greer, President of Edanz, said of the relationship, “by its nature, open access has a strong capacity for accessibility and inclusiveness. BioMed Central therefore provides authors a rapid and effective way to reach their target audience. Both BioMed Central and Edanz are committed to further integrating scientists from East Asia and the developing world into the global research community. With many authors finding that language is a barrier to publication success, this relationship provides authors an opportunity to have an experienced native-English scientist raise the language of their paper to the international standard needed for acceptance. We look forward to helping BioMed Central authors worldwide reach their publication goals.”
- ENDS -
PR Manager, BioMed Central
Tel: +44 (0) 20 3192 2363
Notes to Editors
1. Edanz provides scientific editing and related services that raise the quality of manuscripts to the international standard needed for acceptance. The Edanz team of native English-speaking experts, covering all scientific disciplines, helps authors worldwide reach their publication goals. The only international editing service to be localized in China and Japan, Edanz understands the challenges faced by scientists whose first language is not English in achieving publication success.